Filing Flows › Comparisons › STTK vs CPHI
Shattuck Labs vs China Pharma Holdings: STTK and CPHI compared
Shattuck Labs is the larger company: $1.0M of revenue in its latest quarter (Q3 2025) against $948K for China Pharma Holdings (Q2 2026). China Pharma Holdings is growing faster (-8% against -67% a year earlier).
Where the money goes: STTK and CPHI
Shattuck Labs (STTK) · Q3 2025
Shattuck Labs, Q3 2025: revenue $1.0M (-67% year over year), net loss $10.1M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.
China Pharma Holdings (CPHI) · Q2 2026
China Pharma Holdings, Q2 2026: revenue $948K (-8% year over year), operating margin -151.0%, net loss $1.5M, operating cash flow −$33K. The chart follows the revenue to costs, profit and cash.
| Shattuck Labs (STTK) | China Pharma Holdings (CPHI) | |
|---|---|---|
| Latest quarter | Q3 2025 | Q2 2026 |
| Revenue | $1.0M | $948K |
| Revenue growth, Y/Y | -67% | -8% |
| Operating margin | n/m | -151.0% |
| Net earnings | −$10.1M | −$1.5M |
| Net margin | — | -153.8% |
| Operating cash flow | −$8.9M | −$33K |
Questions
Which is bigger, Shattuck Labs or China Pharma Holdings?
Shattuck Labs is the larger company: $1.0M of revenue in its latest quarter (Q3 2025) against $948K for China Pharma Holdings (Q2 2026).
Is Shattuck Labs or China Pharma Holdings growing faster?
China Pharma Holdings is growing faster (-8% against -67% a year earlier).
More: Shattuck Labs earnings · how Shattuck Labs makes money · China Pharma Holdings earnings · how China Pharma Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2025; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.